CoChat

Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis

Fireman, E, Vardinon, N, Burke, M, Spizer, S, Levin, S, Endler, A, Stav, D, Topilsky, M, Mann, A, Schwarz, Y, Kivity, S, Greif, J · 1998 · European Respiratory Journal

The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.

Abstract

T-cell types are important in maintaining immune homeostasis in the lung and their imbalance may be associated with several diseases. We examined the relationship between bronchoalveolar lavage (BAL) T-cell subset profiles and the clinical course of 46 patients with idiopathic pulmonary fibrosis (IPF). A flow cytometry cell sorter (FACS) was used to analyse the T-cell subsets. Pulmonary function tests (PFT) were performed at baseline and 6-12 months later. Patients were divided into two groups according to their CD4/CD8 ratio: CD4/CD8 >1 (group 1, n=21); and CD4/CD8 <1 (group 2, n=25). A lower percentage of lymphocytes, a higher percentage of CD8/S6F1 cells (cytotoxic T-lymphocytes) and a higher percentage of neutrophils were found in the BAL in group 2 compared to group 1 (11+/-7.5% versus 19+/-13.2%; p=0.024 and 29.8+/-17.6% versus 13.3+/-6.9%; p=0.068, respectively for lymphocytes and cytotoxic T-lymphocytes; and 8+/-11% versus 29+/-27%; p=0.003 for neutrophils). Inversely, in the peripheral blood, the distribution of CD8/S6F1 cells was lower in group 1 than in group 2 (8.3+/-6.9% versus 33.4+/-16.5%; p=0.0048). The patients were followed over a period of 1 yr in order to test whether those findings could determine efficacy of therapy. The baseline transfer factor of the lung for carbon monoxide (TL,CO) capacity in group 1 and group 2 was 59+/-22% and 51+/-21%, respectively (p=0.29), but only in group 1 was the TL,CO capacity improved significantly in response to steroids treatment after 6-12 months. IPF patients with a higher percentage of lymphocytes, a lower percentage of neutrophils, CD4/CD8 >1 and a low percentage of CD8/S6F1 may have a more benign course of disease. These parameters may identify an early stage of reversible disease responsive to therapy. We conclude that these measurements may be a useful tool in monitoring response to treatment in patients with idiopathic pulmonary fibrosis.

Overview

Integrity signals

Registry

Crossref · 10.1183/09031936.98.11030706

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Cited by

See all 64

Metadata

Authors
Fireman, E., Vardinon, N., Burke, M., Spizer, S., Levin, S., Endler, A., Stav, D., Topilsky, M., Mann, A., Schwarz, Y., Kivity, S., & Greif, J.
Affiliations
  • Tel Aviv University (IL)
  • Tel Aviv Sourasky Medical Center (IL)
  • Wolfson Medical Center (IL)
  • Shmuel Harofeh Hospital (IL)
  • Assaf Harofeh Medical Center (IL)
Venue
European Respiratory Journal
Published
1998-03-01
Volume
11
Issue
3
Pages
706-711
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2120993895
Cited by
64
References
31
Citations by year
2025: 3 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 3 · 2020: 3 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 1 · 2013: 1 · 2012: 4
FWCI
2.01
Type
journal article
Language
en
Open access
closed
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
idiopathic pulmonary fibrosis, T cell subsets, CD4/CD8 ratio, cytotoxic T lymphocytes, bronchoalveolar lavage, neutrophils, corticosteroid therapy response, disease prognosis, immune homeostasis, lung function decline, disease progression prediction
MeSH terms
Bronchoalveolar Lavage Fluid, Cell Count, Cell Separation, Female, Flow Cytometry, Follow-Up Studies, Glucocorticoids, Humans, Male, Middle Aged, Predictive Value of Tests, Prednisone, Pulmonary Fibrosis, Respiratory Function Tests, Time Factors, T-Lymphocyte Subsets, CD4-CD8 Ratio

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1183/09031936.98.11030706
The paper
Fireman, E., Vardinon, N., Burke, M., Spizer, S., Levin, S., Endler, A., Stav, D., Topilsky, M., Mann, A., Schwarz, Y., Kivity, S., & Greif, J. (1998). Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis. European Respiratory Journal. https://doi.org/10.1183/09031936.98.11030706

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.